Concepedia
1
Publications
20
Citations
H-Index
2021
Active since
Affiliations
Kao Corporation (Japan)(Current)
Kazumasa Funabashi is an author at Kao Corporation (Japan) specializing in drug discovery, natural sciences, and molecular biology.
Top concepts
MedicineBiochemistryDrug DiscoveryNatural SciencesMolecular BiologyStructural Biology
Publications per year
2021–2021
Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design
Kazumasa Funabashi, Mizuki Sawata, Anna Nagai et al. · Archives of Biochemistry and Biophysics · 2021 · 20 citations
Inhibitor Design, Drug Target, Biochemistry +8
Rows per page
1–1 of 1